Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis

Abstract Background Vitamin D deficiency and frailty are common with aging. Previous studies examining vitamin D status and frailty have produced mixed results, and in particular, the shape of the association has not been well established. We examined the association between 25-hydroxyvitamin D (25O...

Full description

Bibliographic Details
Main Authors: Sang Yhun Ju, June Young Lee, Do Hoon Kim
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Geriatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12877-018-0904-2
_version_ 1818291134441455616
author Sang Yhun Ju
June Young Lee
Do Hoon Kim
author_facet Sang Yhun Ju
June Young Lee
Do Hoon Kim
author_sort Sang Yhun Ju
collection DOAJ
description Abstract Background Vitamin D deficiency and frailty are common with aging. Previous studies examining vitamin D status and frailty have produced mixed results, and in particular, the shape of the association has not been well established. We examined the association between 25-hydroxyvitamin D (25OHD) serum levels and frailty by performing a systematic review and dose-response meta-analysis. Methods We searched the PubMed, EMBASE and Cochrane Library databases of Elsevier through February 2017. Cross-sectional and cohort studies that reported adjusted risk ratios with 95% confidence intervals (CI) for frailty with ≥3 categories of 25OHD serum levels were selected. Data extraction was performed independently by two authors. The reported risk estimates for 25OHD categories were recalculated, employing a comprehensive trend estimation from summarized dose-response data. Results The pooled risk estimate of frailty syndrome per 25 nmol/L increment in serum 25OHD concentration was 0.88 (95% CI = 0.82–0.95, I 2 = 86.8%) in the 6 cross-sectional studies and 0.89 (95% CI = 0.85–0.94, I 2 = 0.0%) in the 4 prospective cohort studies. Based on the Akaike information criteria (AIC), a linear model was selected (AIC for the nonlinear model: − 5.4, AIC for the linear model: − 6.8 in the prospective cohort studies; AIC for the linear model: − 13.6, AIC for the nonlinear model: − 1.77 in the cross-sectional studies). Conclusions This dose-response meta-analysis indicates that serum 25OHD levels are significantly and directly associated with the risk of frailty. Further studies should address the underlying mechanisms to explain this relationship and to determine whether vitamin D supplementation is effective for preventing frailty syndrome.
first_indexed 2024-12-13T02:39:14Z
format Article
id doaj.art-755c94d2d1944fa88c9adaff87bc4747
institution Directory Open Access Journal
issn 1471-2318
language English
last_indexed 2024-12-13T02:39:14Z
publishDate 2018-09-01
publisher BMC
record_format Article
series BMC Geriatrics
spelling doaj.art-755c94d2d1944fa88c9adaff87bc47472022-12-22T00:02:20ZengBMCBMC Geriatrics1471-23182018-09-0118111110.1186/s12877-018-0904-2Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysisSang Yhun Ju0June Young Lee1Do Hoon Kim2Department of Family Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDepartment of Biostatistics, Korea University College of MedicineDepartment of Family Medicine, Korea University Ansan HospitalAbstract Background Vitamin D deficiency and frailty are common with aging. Previous studies examining vitamin D status and frailty have produced mixed results, and in particular, the shape of the association has not been well established. We examined the association between 25-hydroxyvitamin D (25OHD) serum levels and frailty by performing a systematic review and dose-response meta-analysis. Methods We searched the PubMed, EMBASE and Cochrane Library databases of Elsevier through February 2017. Cross-sectional and cohort studies that reported adjusted risk ratios with 95% confidence intervals (CI) for frailty with ≥3 categories of 25OHD serum levels were selected. Data extraction was performed independently by two authors. The reported risk estimates for 25OHD categories were recalculated, employing a comprehensive trend estimation from summarized dose-response data. Results The pooled risk estimate of frailty syndrome per 25 nmol/L increment in serum 25OHD concentration was 0.88 (95% CI = 0.82–0.95, I 2 = 86.8%) in the 6 cross-sectional studies and 0.89 (95% CI = 0.85–0.94, I 2 = 0.0%) in the 4 prospective cohort studies. Based on the Akaike information criteria (AIC), a linear model was selected (AIC for the nonlinear model: − 5.4, AIC for the linear model: − 6.8 in the prospective cohort studies; AIC for the linear model: − 13.6, AIC for the nonlinear model: − 1.77 in the cross-sectional studies). Conclusions This dose-response meta-analysis indicates that serum 25OHD levels are significantly and directly associated with the risk of frailty. Further studies should address the underlying mechanisms to explain this relationship and to determine whether vitamin D supplementation is effective for preventing frailty syndrome.http://link.springer.com/article/10.1186/s12877-018-0904-2Vitamin D25-hydroxyvitamin DFrailtyElderlyCohort studiesCross-sectional studies
spellingShingle Sang Yhun Ju
June Young Lee
Do Hoon Kim
Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis
BMC Geriatrics
Vitamin D
25-hydroxyvitamin D
Frailty
Elderly
Cohort studies
Cross-sectional studies
title Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis
title_full Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis
title_fullStr Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis
title_full_unstemmed Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis
title_short Low 25-hydroxyvitamin D levels and the risk of frailty syndrome: a systematic review and dose-response meta-analysis
title_sort low 25 hydroxyvitamin d levels and the risk of frailty syndrome a systematic review and dose response meta analysis
topic Vitamin D
25-hydroxyvitamin D
Frailty
Elderly
Cohort studies
Cross-sectional studies
url http://link.springer.com/article/10.1186/s12877-018-0904-2
work_keys_str_mv AT sangyhunju low25hydroxyvitamindlevelsandtheriskoffrailtysyndromeasystematicreviewanddoseresponsemetaanalysis
AT juneyounglee low25hydroxyvitamindlevelsandtheriskoffrailtysyndromeasystematicreviewanddoseresponsemetaanalysis
AT dohoonkim low25hydroxyvitamindlevelsandtheriskoffrailtysyndromeasystematicreviewanddoseresponsemetaanalysis